ADRA1D encodes the alpha-1D adrenergic receptor, a G protein-coupled receptor that binds catecholamine ligands norepinephrine and epinephrine and signals through the Gq/G11 pathway to stimulate phosphatidylinositol-calcium second messenger signaling 12. The receptor undergoes endogenous N-terminal cleavage at Leu90/Val91 in human cells, generating a truncated isoform with enhanced pharmacodynamic properties 3. ADRA1D plays critical roles in cardiovascular regulation, particularly in blood pressure circadian variation through vascular smooth muscle cell function and adrenergic signaling responsiveness 4. The receptor also functions as a survival factor in skeletal muscle cells, with knockdown resulting in increased cell death 5. In pathological contexts, ADRA1D expression is reduced in cutaneous melanoma, where overexpression inhibits tumor cell proliferation, invasion, and angiogenesis by suppressing the HIF-1α/VEGF pathway 6. Additionally, ADRA1D overexpression protects against oxygen-glucose deprivation-induced neuronal cell death by modulating intracellular calcium levels and reducing apoptosis, suggesting potential therapeutic relevance for vascular dementia 7. The receptor is also implicated in diabetes-induced vascular injury, where it contributes to endothelial-to-mesenchymal transition through calcium-dependent signaling pathways 8.